These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37453830)

  • 1. Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions.
    Ungar WJ; Hayeems RZ; Marshall CR; Gillespie MK; Szuto A; Chisholm C; James Stavropoulos D; Huang L; Jarinova O; Wu V; Tsiplova K; Lau L; Lee W; Venkataramanan V; Sawyer S; Mendoza-Londono R; Somerville MJ; Boycott KM;
    Clin Ther; 2023 Aug; 45(8):702-709. PubMed ID: 37453830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada.
    Weymann D; Buckell J; Fahr P; Loewen R; Ehman M; Pollard S; Friedman JM; Stockler-Ipsiroglu S; Elliott AM; Wordsworth S; Buchanan J; Regier DA
    JAMA Netw Open; 2024 Jul; 7(7):e2420842. PubMed ID: 38985473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care.
    Watson JM; Crosby H; Dale VM; Tober G; Wu Q; Lang J; McGovern R; Newbury-Birch D; Parrott S; Bland JM; Drummond C; Godfrey C; Kaner E; Coulton S;
    Health Technol Assess; 2013 Jun; 17(25):1-158. PubMed ID: 23796191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The West Midlands ActiVe lifestyle and healthy Eating in School children (WAVES) study: a cluster randomised controlled trial testing the clinical effectiveness and cost-effectiveness of a multifaceted obesity prevention intervention programme targeted at children aged 6-7 years.
    Adab P; Barrett T; Bhopal R; Cade JE; Canaway A; Cheng KK; Clarke J; Daley A; Deeks J; Duda J; Ekelund U; Frew E; Gill P; Griffin T; Hemming K; Hurley K; Lancashire ER; Martin J; McGee E; Pallan MJ; Parry J; Passmore S
    Health Technol Assess; 2018 Feb; 22(8):1-608. PubMed ID: 29436364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mobile Health Intervention for Patients With Depressive Symptoms: Protocol for an Economic Evaluation Alongside Two Randomized Trials in Brazil and Peru.
    Vera Cruz Dos Santos D; Coelho de Soárez P; Cavero V; U Rocha TI; Aschar S; Daley KL; Garcia Claro H; Abud Scotton G; Fernandes I; Diez-Canseco F; Brandt LR; Toyama M; Martins Castro HC; Miranda JJ; Araya R; Quayle J; Rossi Menezes P
    JMIR Res Protoc; 2021 Oct; 10(10):e26164. PubMed ID: 34643538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.
    Burr JM; Mowatt G; Hernández R; Siddiqui MA; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A; Deeks J; Cairns J; Wormald R; McPherson S; Rabindranath K; Grant A
    Health Technol Assess; 2007 Oct; 11(41):iii-iv, ix-x, 1-190. PubMed ID: 17927922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.